Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ResMed Inc. (RMD : NYSE)

• Company Description    ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. Number of Employees: 10,600

• Price / Volume Information    Yesterday's Closing Price: $252.55 Daily Weekly Monthly 20 Day Moving Average: 1,269,651 shares Shares Outstanding: 145.68 (millions) Market Capitalization: $36,790.98 (millions) Beta: 0.87 52 Week High: $293.81 52 Week Low: $199.92 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.13% -1.59% 12 Week 3.54% -0.97% Year To Date 4.85% 2.21%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9001 SPECTRUM CENTER BLVD. - SAN DIEGO,CA 92123 USA ph: 858-836-5000 fax: 858-836-5501 investorrelations@resmed.com http://www.resmed.com

• General Corporate Information    Officers Michael J. Farrell - Chief Executive Officer and Chairman Brett A. Sandercock - Chief Financial Officer Peter C. Farrell - Director and Chair Emeritus Carol J. Burt - Director Christopher DelOrefice - Director Peer Information ResMed Inc. (BJCT) ResMed Inc. (CADMQ) ResMed Inc. (APNO) ResMed Inc. (UPDC) ResMed Inc. (IMTIQ) ResMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 761152107 SIC: 3841 Fiscal Year Fiscal Year End: June Last Reported Quarter: 12/01/25 Next Expected EPS Date: 04/22/26 Share - Related Items Shares Outstanding: 145.68 Most Recent Split Date: 8.00 (2.00:1) Beta: 0.87 Market Capitalization: $36,790.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.95% Current Fiscal Quarter EPS Consensus Estimate: $2.77 Indicated Annual Dividend: $2.40 Current Fiscal Year EPS Consensus Estimate: $10.97 Payout Ratio: 0.23 Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: -0.04 Estmated Long-Term EPS Growth Rate: 13.72% Last Dividend Paid: 11/13/2025 - $0.60 Next EPS Report Date: 04/22/26

• Fundamental Ratios P/E Current FY Estimate: 23.02 Trailing 12 Months: 24.57 PEG Ratio: 1.68 Price Ratios Price/Book: 5.82 Price/Cash Flow: 22.55 Price / Sales: 6.82 EPS Growth vs. Year Ago Period: 15.64% vs. Previous Quarter: 10.20% Sales Growth vs. Year Ago Period: 10.98% vs. Previous Quarter: 6.53% ROE 12/31/25 - 25.20 09/30/25 - 25.45 06/30/25 - 25.62 ROA 12/31/25 - 18.55 09/30/25 - 18.68 06/30/25 - 18.69 Current Ratio 12/31/25 - 3.06 09/30/25 - 2.89 06/30/25 - 3.44 Quick Ratio 12/31/25 - 2.32 09/30/25 - 2.13 06/30/25 - 2.53 Operating Margin 12/31/25 - 27.96 09/30/25 - 27.70 06/30/25 - 27.34 Net Margin 12/31/25 - 27.53 09/30/25 - 27.35 06/30/25 - 27.22 Pre-Tax Margin 12/31/25 - 33.69 09/30/25 - 33.11 06/30/25 - 32.60 Book Value 12/31/25 - 43.39 09/30/25 - 41.94 06/30/25 - 40.70 Inventory Turnover 12/31/25 - 2.31 09/30/25 - 2.32 06/30/25 - 2.33 Debt-to-Equity 12/31/25 - 0.06 09/30/25 - 0.07 06/30/25 - 0.11 Debt-to-Capital 12/31/25 - 6.01 09/30/25 - 6.26 06/30/25 - 9.94

Powered by Zacks Investment Research ©